Cargando…

Survival with low- and high-flux dialysis

BACKGROUND: Besides advances in haemodialysis (HD), mortality rates are still high. The effect of the different types of HD membranes on survival is still a controversial issue. The aim of this COSMOS (Current management Of Secondary hyperparathyroidism: a Multicentre Observational Study) analysis w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Álvarez, Emilio, Rodríguez-García, Minerva, Locatelli, Francesco, Zoccali, Carmine, Martín-Malo, Alejandro, Floege, Jürgen, Ketteler, Markus, London, Gerard, Górriz, José L, Rutkowski, Boleslaw, Ferreira, Anibal, Pavlovic, Drasko, Cannata-Andía, Jorge B, Fernández-Martín, José L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323142/
https://www.ncbi.nlm.nih.gov/pubmed/34345415
http://dx.doi.org/10.1093/ckj/sfaa233
_version_ 1783731187053756416
author Sánchez-Álvarez, Emilio
Rodríguez-García, Minerva
Locatelli, Francesco
Zoccali, Carmine
Martín-Malo, Alejandro
Floege, Jürgen
Ketteler, Markus
London, Gerard
Górriz, José L
Rutkowski, Boleslaw
Ferreira, Anibal
Pavlovic, Drasko
Cannata-Andía, Jorge B
Fernández-Martín, José L
author_facet Sánchez-Álvarez, Emilio
Rodríguez-García, Minerva
Locatelli, Francesco
Zoccali, Carmine
Martín-Malo, Alejandro
Floege, Jürgen
Ketteler, Markus
London, Gerard
Górriz, José L
Rutkowski, Boleslaw
Ferreira, Anibal
Pavlovic, Drasko
Cannata-Andía, Jorge B
Fernández-Martín, José L
author_sort Sánchez-Álvarez, Emilio
collection PubMed
description BACKGROUND: Besides advances in haemodialysis (HD), mortality rates are still high. The effect of the different types of HD membranes on survival is still a controversial issue. The aim of this COSMOS (Current management Of Secondary hyperparathyroidism: a Multicentre Observational Study) analysis was to survey, in HD patients, the relationship between the use of conventional low- or high-flux membranes and all-cause and cardiovascular mortality. METHODS: COSMOS is a multicentre, open-cohort, 3-year prospective study, designed to evaluate mineral and bone disorders in the European HD population. The present analysis included 5138 HD patients from 20 European countries, 3502 randomly selected at baseline (68.2%), plus 1636 new patients with <1 year on HD (31.8%) recruited to replace patients who died, were transplanted, switched to peritoneal dialysis or lost to follow-up by other reasons. Cox-regression analysis with time-dependent variables, propensity score matching and the use of an instrumental variable (facility-level analysis) were used. RESULTS: After adjustments using three different multivariate models, patients treated with high-flux membranes showed a lower all-cause and cardiovascular mortality risks {hazard ratio (HR) = 0.76 [95% confidence interval (CI) 0.61–0.96] and HR = 0.61 (95% CI 0.42–0.87), respectively}, that remained significant after matching by propensity score for all-cause mortality (HR = 0.69, 95% CI 0.52–0.93). However, a facility-level analysis showed no association between the case-mix-adjusted facility percentage of patients dialysed with high-flux membranes and all-cause and cardiovascular mortality. CONCLUSIONS: High-flux dialysis was associated with a lower relative risk of all-cause and cardiovascular mortality. However, dialysis facilities using these dialysis membranes to a greater extent did not show better survival.
format Online
Article
Text
id pubmed-8323142
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-83231422021-08-02 Survival with low- and high-flux dialysis Sánchez-Álvarez, Emilio Rodríguez-García, Minerva Locatelli, Francesco Zoccali, Carmine Martín-Malo, Alejandro Floege, Jürgen Ketteler, Markus London, Gerard Górriz, José L Rutkowski, Boleslaw Ferreira, Anibal Pavlovic, Drasko Cannata-Andía, Jorge B Fernández-Martín, José L Clin Kidney J Original Articles BACKGROUND: Besides advances in haemodialysis (HD), mortality rates are still high. The effect of the different types of HD membranes on survival is still a controversial issue. The aim of this COSMOS (Current management Of Secondary hyperparathyroidism: a Multicentre Observational Study) analysis was to survey, in HD patients, the relationship between the use of conventional low- or high-flux membranes and all-cause and cardiovascular mortality. METHODS: COSMOS is a multicentre, open-cohort, 3-year prospective study, designed to evaluate mineral and bone disorders in the European HD population. The present analysis included 5138 HD patients from 20 European countries, 3502 randomly selected at baseline (68.2%), plus 1636 new patients with <1 year on HD (31.8%) recruited to replace patients who died, were transplanted, switched to peritoneal dialysis or lost to follow-up by other reasons. Cox-regression analysis with time-dependent variables, propensity score matching and the use of an instrumental variable (facility-level analysis) were used. RESULTS: After adjustments using three different multivariate models, patients treated with high-flux membranes showed a lower all-cause and cardiovascular mortality risks {hazard ratio (HR) = 0.76 [95% confidence interval (CI) 0.61–0.96] and HR = 0.61 (95% CI 0.42–0.87), respectively}, that remained significant after matching by propensity score for all-cause mortality (HR = 0.69, 95% CI 0.52–0.93). However, a facility-level analysis showed no association between the case-mix-adjusted facility percentage of patients dialysed with high-flux membranes and all-cause and cardiovascular mortality. CONCLUSIONS: High-flux dialysis was associated with a lower relative risk of all-cause and cardiovascular mortality. However, dialysis facilities using these dialysis membranes to a greater extent did not show better survival. Oxford University Press 2020-12-26 /pmc/articles/PMC8323142/ /pubmed/34345415 http://dx.doi.org/10.1093/ckj/sfaa233 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Sánchez-Álvarez, Emilio
Rodríguez-García, Minerva
Locatelli, Francesco
Zoccali, Carmine
Martín-Malo, Alejandro
Floege, Jürgen
Ketteler, Markus
London, Gerard
Górriz, José L
Rutkowski, Boleslaw
Ferreira, Anibal
Pavlovic, Drasko
Cannata-Andía, Jorge B
Fernández-Martín, José L
Survival with low- and high-flux dialysis
title Survival with low- and high-flux dialysis
title_full Survival with low- and high-flux dialysis
title_fullStr Survival with low- and high-flux dialysis
title_full_unstemmed Survival with low- and high-flux dialysis
title_short Survival with low- and high-flux dialysis
title_sort survival with low- and high-flux dialysis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323142/
https://www.ncbi.nlm.nih.gov/pubmed/34345415
http://dx.doi.org/10.1093/ckj/sfaa233
work_keys_str_mv AT sanchezalvarezemilio survivalwithlowandhighfluxdialysis
AT rodriguezgarciaminerva survivalwithlowandhighfluxdialysis
AT locatellifrancesco survivalwithlowandhighfluxdialysis
AT zoccalicarmine survivalwithlowandhighfluxdialysis
AT martinmaloalejandro survivalwithlowandhighfluxdialysis
AT floegejurgen survivalwithlowandhighfluxdialysis
AT kettelermarkus survivalwithlowandhighfluxdialysis
AT londongerard survivalwithlowandhighfluxdialysis
AT gorrizjosel survivalwithlowandhighfluxdialysis
AT rutkowskiboleslaw survivalwithlowandhighfluxdialysis
AT ferreiraanibal survivalwithlowandhighfluxdialysis
AT pavlovicdrasko survivalwithlowandhighfluxdialysis
AT cannataandiajorgeb survivalwithlowandhighfluxdialysis
AT fernandezmartinjosel survivalwithlowandhighfluxdialysis
AT survivalwithlowandhighfluxdialysis